Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Pharmas Threaten Production Halt If Price Increases Barred

This article was originally published in PharmAsia News

Executive Summary

Indian pharmaceuticals are threatening to stop making certain drugs if the government does not allow price increases. B.N. Singh, president of the Indian Drug Manufacturers' Association, said his group has appealed to the Ministry of Chemicals and Fertilisers to be allowed to raise prices to reflect the higher cost of bulk drugs and packaging materials. The IDMA also says Indian drug makers face increased costs of freight and accommodation and can no longer absorb them. The group cites the recent substantial increase in the cost of bulk drugs imported from China. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts